Fundraising Fox
Cross-Border Impact Ventures
Impact investorToronto · Series A–Series B · 11 people tracked
Find your way into Cross-Border Impact Ventures
Sign up to see every warm intro you have to Cross-Border Impact Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cross-Border Impact Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The firm invests in companies commercializing globally relevant medical devices, diagnostics, therapeutics and digital health innovations that address market opportunities in women, children and adolescent health. It focuses on four areas: sexual and reproductive health; maternal, newborn and child health; general health including chronic diseases; and health software infrastructure. Applying a gender and diversity lens, it targets companies addressing gender health inequalities and pursues both positive impact and financial returns. As hands-on investors, the firm supports management teams with access to new markets, unique forms of capital and health technology expertise across North America, Europe and global markets.
Source: firm website, verified Sep 29, 2026.
Team · 11 people
from the firm's website & curated & public directories
What they invest in
from 10 of 11 portfolio companiesHealthtech ×7Digital Health ×6Medical Devices ×6AI & Machine Learning ×4FemTech ×4Biotech ×2Wellness & Fitness ×2AgTech ×1
HQs:United States×3United Kingdom×2
Investments · 11 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12022 · 13 dated
Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making.
AI & Machine LearningBiotechMedical DevicesOxford, GB
Andreas Halner(Founder and Head of Healthcare AI)inHeinrich Roder(Chief Technology Officer)inDaniel Szulc(Chief Product Officer)in
Co-investorsEka VenturesMeridian Health VenturesUK Innovation & Science Seed FundCivilization Ventures Management, LlcDigitalDx VenturesOnstage+1 more
Axena Health develops digital therapeutic devices for women's pelvic health, specifically treating urinary and fecal incontinence through at-home pelvic floor muscle training.
Digital HealthFemTechHealthtechMedical DevicesAuburndale, US
Samantha Pulliam(CEO and Chief Medical Officer)inVincent Ricci(Executive Officer)Jim O'Connor(Executive Officer)inShacey Petrovic(Executive Officer, Director)inEileen Maus(Executive Officer, Director)in
BoardJonathan Dean(Director)
Co-investorsAvestria VenturesCatalio Capital Management, LPSolas BioVentures
Bactolife develops Binding Proteins for use in functional foods for humans and in animal feed, aimed at supporting healthy digestion and livestock health.
AgTechBiotechFoodTech
Co-investorsNovo Holdings
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.
AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US
Amit Gupta(Co-founder, Advisor)inMozziyar Etemadi(Co-founder, Head of AI)Omer Inan(Co-founder, Chief Scientific Officer)inAndrew Carek(Co-founder, Chief Technical Officer)inEric Meizlish(Chief Executive Officer)inJohn D. Martin(Chief Medical Officer)in
Co-investorsBayMed Venture PartnersBroadview VenturesLaerdal Million Lives FundOSF VenturesPortal InnovationsArboretum Ventures+1 more
Daye offers at-home diagnostic tests for hormonal health, vaginal microbiome, and STI screening, alongside consulting services with fertility and gynecological nurses.
Digital HealthFemTechHealthtechWellness & Fitness
Valentina(Founder & CEO)Valentina Milanova(Founder)
Co-investorsCrane Venture PartnersGuinness VenturesImpetus CapitalJazzya InvestmentsKindred CapitalMyelin VC+2 more
mOm develops the mOm Essential, a neonatal incubator that warms newborns to normal body temperature to prevent hypothermia and avoidable NICU admissions.
HardwareHealthtechMedical DevicesEdinburgh, GB
James Roberts(CEO, Co-Founder & Board)inRichard Marlow(CFO (Board))inDaniel Green(Chief Operating Officer)in
Co-investorsCambridge Angels groupConduit Connect
OncoLens provides a platform that connects cancer care teams and enables multidisciplinary cancer management, helping cancer centers coordinate care, manage tumor boards, and access clinical trials and biomarker testing.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSaaS
Anju Mathew(Co-Founder and CEO)inLijo Simpson(Chief Medical Officer)in
Co-investorsAtlanta Technology AngelsBIP VenturesMartin VenturesSeedToBBIP Capital
Pendulum is a probiotic and prebiotic supplement company that develops clinically-tested products targeting gut health, metabolic function, and glucose control, including proprietary strains like live Akkermansia.
HealthtechWellness & Fitness
Co-investorsATEL VenturesDCVC (Data Collective)Felicis VenturesLowercarbon CapitalSequoia CapitalSunflower Capital Management Fund+3 more
Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth.
Digital HealthFemTechHealthtechMedical DevicesSan Ramon, US
Neil P. Ray(Executive Officer, Director)inMichael Nagel(Chief Executive Officer)in
BoardCharles McDonald(Director)John Maroney(Director)
Co-investorsAvestria VenturesBand of AngelsFemHealth VenturesSteelSky VenturesTri-Valley VenturesBill & Melinda Gates Foundation+6 more
Sonio is a cloud-native, AI-powered platform that standardizes and automates fetal ultrasound workflows, covering image acquisition, reporting, quality review, and billing handoff.
AI & Machine LearningDigital HealthFemTech
Cecile Brosset Dubois(Founder)in
Co-investorsElaiaOneRagtimeSTATION FBpifrance
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Oxford Cancer Analytics
Frequently asked questions
- How many investments has Cross-Border Impact Ventures made?
- Cross-Border Impact Ventures has 11 tracked investments, including 1 dated in the last 24 months.
- What stage does Cross-Border Impact Ventures invest at?
- Cross-Border Impact Ventures invests at the Series A, Series B stages.
- What is Cross-Border Impact Ventures's typical check size?
- Cross-Border Impact Ventures typically writes checks of $2M – $10M.
- What sectors does Cross-Border Impact Ventures focus on?
- Cross-Border Impact Ventures focuses on AI & Machine Learning, Biotech, Digital Health, FemTech, Healthtech, Impact & Social Good, Medical Devices, SaaS.
- Where is Cross-Border Impact Ventures located?
- Cross-Border Impact Ventures is headquartered in Toronto, CA.
- Who does Cross-Border Impact Ventures co-invest with?
- Cross-Border Impact Ventures most often shares deals with Avestria Ventures, DCVC (Data Collective), Felicis Ventures, among 42 tracked co-investors.
Similar investors
Jaza Rift Ventures is a healthcare-focused investment platform for Africa combining an investment holding company, a transaction advisory firm, and a global health innovation lab (venture studio). It backs digital health, medtech, biotech, and assistive technology founders from pre-seed to Series A.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Global Health Investment Corporation (GHIC) is a nonprofit that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products improving global public health and health equity.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
Portfolia operates thematic venture funds designed by and for women investors, backing companies in women's health, active aging, and longevity, alongside a community of over 2,200 women investors across 48 states and 20 countries.